Skip to main content
Premium Trial:

Request an Annual Quote

Caliper, Shimadzu Settle Patent Litigation

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Caliper Life Sciences today said that it had reached a settlement agreement with Shimadzu over a patent infringement suit it had filed against the Japanese firm two months ago.

Caliper had filed the suit in January in the US District Court for the Eastern District of Texas, alleging that Shimadzu's MCE-202 MultiNA instrument system, a microchip-based electrophoresis system that performs DNA and RNA size confirmation and quantitation, infringed 11 patents covering its LabChip technology.

According to Hopkinton, Mass.-based Caliper, Shimadzu denied infringing the patents, but it agreed to discontinue sales of the MultiNA system in the US. Further terms of the settlement agreement were not disclosed.

The Scan

Cell Atlas of Human Lung Development Gives View of Developing Airway

Researchers have generated a cell atlas of human lung development, which they report in Cell.

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.